AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...
According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...
The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...
New gene therapy modalities, such as CRISPR guide RNA (single guide ribonucleic acid [sgRNA]) and messenger RNA (mRNA), ...
With the addition of Casgevy, Children’s Hospital Los Angeles now offers two gene therapies for sickle cell, the first being Lyfgenia.
Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...
AZoLifeSciences on MSN5d
How Proteins Are Made: From DNA to FunctionProtein synthesis is vital for life, translating genetic information from DNA to functional proteins through transcription ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback